You searched for "market"

4080 results found

Chronic rhinosinusitis, are we treating the same disease?

Chronic rhinosinusitis (CRS) is a heterogenic disease. The effects of heterogeneity on treatment outcome are not very clear. Authors used clinical features such as endoscopic findings scores and full blood count findings in addition to analysis of 35 molecular markers....

New biomarkers for salivary gland tumours

Salivary gland tumours comprise approximately 6-8% of head and neck neoplasms. Elevated haematological inflammatory markers, such as neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR), have been shown to be predictive and prognostic in various malignancies. This...

Chronic rhinitis endotypes

Chronic rhinitis (CR) is common with up to 30% of the population affected, with a significant impact on quality of life. CR includes several phenotypes with different pathogenesis including allergy, autoimmune, age, occupation, pregnancy, neurogenic and drugs. Such variation means...

Surviving oropharyngeal squamous cell carcinoma – does subsite matter?

Human papilloma virus (HPV) status is a known prognostic factor in oropharyngeal squamous cell carcinoma (OPSCC). The eighth edition of American Joint Cancer Committee (AJCC) has modified the TNM staging to reflect this. However, subsite as an independent prognostic factor...

Hurdle jumping

This article deserves a little attention, rather like settling into conversation. As the writers state, listening is an effort and is a tricky field of study when combining multiple physiological measures. In order to gain an understanding, they suggest: consider...

Audiology In This Issue - Trainee Takeover

Guest Section Editors Lizanne Steenkamp,Lecturer in Audiology, Speech and Hearing Sciences, Queen Margaret University, Edinburgh, UK. lsteenkamp@qmu.ac.uk Rosalyn Parker, CS MSc FBSA,Evaluation Healthcare Scientist, Northern Medical Physics and Clinical Engineering, UK. Rosalyn.parker2@nhs.net The decision to become an audiology professional (i.e....

Royal Society of Medicine – the year ahead

Professor Peter Andrews and Professor Manohar Bance look forward to 2022-23.

Translating research – transforming lives: the BACO 2020 academic programme

The main attraction of any conference or event is, of course, the academic programme of lectures, workshops and education. Hisham Mehanna, BACO 2020 Academic Chair, and Paul Nankivell, Academic Vice Chair, give us an overview of what to expected in...

Optimising hearing aid processing for music appreciation

Hearing aid manufacturers’ main focus has, up until recently, been improvement of speech intelligibility. Today’s hearing aid users have much broader demands however and often cite improved music perception as a key outcome or goal. Drs Tish Ramirez and Rebecca...

Using telehealth to engage teenagers

Can we use a teenager’s love of gadgets to re-engage them with their hearing technology? Gwen Carr reports on an innovative use of telehealth to support teenagers who are no longer visiting their hearing healthcare professionals. Parents of children and...

Are today’s implantable hearing devices better than conventional devices for patients with conductive and mixed hearing loss?

In March 2014, we published a paper in ENT & Audiology News, with a similar title. Below, an updated overview is presented of available devices (early 2021) for patients with conductive/mixed hearing loss. The focus is on effectiveness. Patients with...

A new clinical device to monitor nasal blockage

Chia-Hung Li, a Medical Device PhD student from University College London’s (UCL) Institute of Healthcare Engineering, is currently leading a PhD project to develop a clinical device to monitor nasal blockage. Jo Rimmer spoke to him about what he is...